Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Vincent

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
BMC Cancer|July 8, 2022
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trialEdward Yu, Alison L Allan, Michael Sanatani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 studyGlenwood D Goss, Andrew Arnold, Frances A Shepherd, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled TrialBrian P Yaremko, Dante P I Capaldi, Khadija Sheikh, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
BMC Cancer|July 8, 2022
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trialEdward Yu, Alison L Allan, Michael Sanatani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 studyGlenwood D Goss, Andrew Arnold, Frances A Shepherd, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled TrialBrian P Yaremko, Dante P I Capaldi, Khadija Sheikh, et al.
Pageof 4